The Pituitary Gland in Pregnancy

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
bookPart
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER
Citação
Glezer, A.; Bronstein, M. D.. The Pituitary Gland in Pregnancy. In: . THE PITUITARY: ELSEVIER, 2022. p.429-445.
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
During pregnancy, pituitary morphology and function are modified by placental hormonal secretion. Pituitary volume is increased due to lactotroph hypertrophy and hyperplasia. Placental sex steroids inhibit GnRH and gonadotropin secretion. The placenta secretes a variant isoform of GH, increasing IGF-1 levels. TSH secretion decreases in the first trimester, secondary to thyroid stimulation by human chorionic gonadotropin. Hepatic production of thyroid-binding globulin is stimulated by estrogens, increasing total T4 and T3. Placental CRH stimulates pituitary and placental ACTH, increasing cortisol levels throughout pregnancy. Infertility is common in patients harboring pituitary tumors. Pathophysiology includes hormonal hypersecretion and tumoral mass effect. Hypopituitarism can also result from surgery and/or radiotherapy for pituitary adenoma treatment. Hyperprolactinemia, occurring in prolactinomas, the most common subtype of pituitary adenomas, and other pituitary tumors, inhibits GnRH pulsatility. Different mechanisms seem to play a role in hypogonadism of patients harboring acromegaly: tumoral gonadotroph compression, hyperprolactinemia, and GH/IGF-1 excess disrupting gonadal axis. In Cushing's disease, hypogonadism is mainly due to the negative impact of hypercortisolism and hyperandrogenism in the gonadotrophic axis. Clinically nonfunctioning pituitary tumors seldom are associated with pregnancy. In pituitary adenomas, treatment is often necessary to control hormonal hypersecretion and tumor mass effect related to infertility. Other causes of infertility include lymphocytic hypophysitis and Sheehan's syndrome. This chapter reviews the pathophysiology, diagnosis, and therapeutic approaches for women with pituitary diseases, before and during pregnancy, in order to induce fertility and avoid the deleterious effects of hormonal hyper- or hyposecretion. © 2022 Elsevier Inc. All rights reserved.
Palavras-chave
Diabetes insipidus, Dopamine agonist, Hypophysitis, Hypopituitarism, Pituitary tumors, Pregnancy, Sheehan's syndrome, Somatostatin receptor ligand
Referências
  1. Goluboff, L.G., Ezrin, C., Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis (1969) J Clin Endocrinol Metab, 29, pp. 1533-1538
  2. Elster, A.D., Sanders, T.G., Vines, F.S., Size and shape of the pituitary gland during pregnancy and post partum: measurement with MR imaging (1991) Radiology, 181, pp. 531-535
  3. Foyouzi, N.F.Y., Norwitz, E.R., Pituitary gland and pregnancy (2004) Obstet Gynecol Clin N Am, 31, pp. 873-892
  4. Rigg, L.A., Lein, A., Yen, S.S., Pattern of increase in circulating prolactin levels during human gestation (1977) Am J Obstet Gynecol, 129, pp. 454-456
  5. Ferriani, R.A., Silva-de-Sà, M., de-Lima-Filho, E.C., A comparative study of longitudinal and cross-sectional changes in plasma levels of prolactin and estriol during normal pregnancy (1986) Braz J Med Biol Res, 19, pp. 183-188
  6. Riddick, D.H., Luciano, A., Kusmik, W.F., Maslar, I.A., Evidence for a nonpituitary source of amniotic fluid PRL (1979) Fertil Steril, 31, pp. 35-39
  7. Karaca, Z., Tanriverdi, F., Unluhizarci, K., Pregnancy and pituitary disorders (2010) Eur J Endocrinol, 162, pp. 453-475
  8. Chen, E.Y., Liao, Y.C., Smith, D.H., The human growth hormone locus: nucleotide sequence, biology, and evolution (1989) Genomics, 4, pp. 479-497
  9. Swenne, I., Hill, D.J., Strain, A.J., Effects of human placental lactogen and growth hormone on the production of insulin and somatomedin C/insulin-like growth factor I by human fetal pancreas in tissue culture (1987) J Endocrinol, 113, pp. 297-303
  10. Caufriez, A., Frankenne, F., Englert, Y., Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy (1990) Am J Physiol, 258, pp. E1014-E1019
  11. Caufriez, A., Frankenne, F., Hennen, G., Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies (1993) Am J Physiol, 265, pp. E572-E577
  12. Chiodini, I.L.M., Pavone, G., Trischittal, V., Scillitani, A., Pregnancy in Cushing's disease shortly after treatment by γ-knife radiosurgery (2004) J Endocrinol Invest, 27, pp. 954-956
  13. Vilar, L., Freitas, M.C., Lima, L.H., Lyra, R., Kater, C.E., Cushing's syndrome in pregnancy: an overview (2007) Arq Bras Endocrinol Metabol, 51, pp. 1293-1302
  14. Benothman, W., Saad, G., Kacem, M., Three successful pregnancies in a patient with recurrent Cushing's disease (2021) Case Rep Endocrinol, 2021, p. 5517303
  15. Berwaerts, J., Verhelst, J., Mahler, C., Abs, R., Cushing's syndrome in pregnancy treated by ketoconazole: case report and review of the literature (1999) Gynecol Endocrinol, 13, pp. 175-182
  16. Woo, I., Ehsanipoor, R.M., Cabergoline therapy for Cushing disease throughout pregnancy (2013) Obstet Gynecol, 122, pp. 485-487
  17. Alsat, E., Guibourdenche, J., Luton, D., Human placental growth hormone (1997) Am J Obstet Gynecol, 177, pp. 1526-1534
  18. Sridharan, K.S.J., Palui, R., Patil, M., Kamalanathan, S., Ramesh, A.S., Kubera, N.S., Diagnosis and treatment outcomes of Cushing’s disease during pregnancy (2021) Pituitary, 24 (5), pp. 670-680
  19. Chaiamnuay, S., Moster, M., Katz, M.R., Successful management of a pregnant woman with a TSH secreting pituitary adenoma with surgical and medical therapy (2003) Pituitary, 6, pp. 109-113
  20. Blackhurst, G., Strachan, M.W., Collie, D., The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy (2002) Clin Endocrinol, 57, pp. 401-404
  21. Bolz, M., Körber, S., Schober, H.C., TSH secreting adenoma of pituitary gland (TSHom)-rare cause of hyperthyroidism in pregnancy (2013) Dtsch Med Wochenschr, 138, pp. 362-366
  22. Yamanaka, Y., Takeuchi, K., Konda, E., Transient postpartum diabetes insipidus in twin pregnancy associated with HELLP syndrome (2002) J Perinat Med, 30, pp. 273-275
  23. Jackson, D.G., Parker, J., Cummings, T., Pituitary thyrotoxicosis presenting as abnormal thyroid function testing during pregnancy: a case report (2021) J Med Case Rep, 15, p. 173
  24. Chi-Hong, N., Chow, W., Lam, K.S., Lee, C.H., An undiagnosed TSH-secreting pituitary macroadenoma found during pregnancy (2021) Endocrinol Diabetes Metab Case Rep, 16, pp. 20-21
  25. Serafini, P.M.E., White, J.S., Restoration of ovarian cyclicity and ovulation induction in hypopituitary women (2001) Pituitary tumors in pregnancy, pp. 173-194. , M. Bronstein (Eds), Boston: Kluwer Academic Publishers
  26. Jallad, R.S., Glezer, A., Machado, M.C., Bronstein, M.D., Pituitary disorders during pregnancy and lactation (2020) Maternal-fetal and neonatal endocrinology physiology, pathophysiology, and clinical management, , C. Kovacs, C. Deal (Eds), London: Elsevier
  27. Rosmino, J., Tkatch, J., Di Paolo, M.V., Non-functioning pituitary adenomas and pregnancy: one-center experience and review of the literature (2021) Arch Endocrinol Metab, 64, pp. 614-622
  28. Ntali, G., Capatina, C., Grossman, A., Clinical review: functioning gonadotroph adenomas (2014) J Clin Endocrinol Metab, 99, pp. 4423-4433
  29. Daughaday, W.H., Trivedi, B., Winn, H.N., Hypersomatotropism in pregnant women, as measured by a human liver radioreceptor assay (1990) J Clin Endocrinol Metab, 70, pp. 215-221
  30. Zhao, Y., Lian, W., Xing, B., Functioning gonadotroph adenoma (2019) Chin Med J (Engl)., 132, pp. 1003-1004
  31. Murata, Y., Ando, H., Nagasaka, T., Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary microadenoma (2003) J Clin Endocrinol Metab, 88, pp. 1988-1993
  32. Sugita, T., Seki, K., Nagai, Y., Successful pregnancy and delivery after removal of gonadotrope adenoma secreting follicle-stimulating hormone in a 29-year-old amenorrheic woman (2005) Gynecol Obstet Invest, 59, pp. 138-143
  33. Marques, P., Gunawardana, K., Grossman, A., Transient diabetes insipidus in pregnancy (2015) Endocrinol Diabetes Metab Case Rep, 2015, p. 150078
  34. Zhang, Y., Chen, C., Lin, M., Successful pregnancy after operation in an infertile woman caused by luteinizing hormone-secreting pituitary adenoma: case report and literature review (2021) BMC Endocr Disord, 21, p. 15
  35. Jemel, M., Kandara, H., Riahi, M., Gestational pituitary apoplexy: case series and review of the literature (2019) J Gynecol Obstet Hum Reprod, 48, pp. 873-881
  36. Oguz, S.H., Soylemezoglu, F., Dagdelen, S., A case of atypical macroprolactinoma presenting with pituitary apoplexy during pregnancy and review of the literature (2019) Gynecol Endocrinol, pp. 1-8
  37. Piantanida, E., Gallo, D., Lombardi, V., Pituitary apoplexy during pregnancy: a rare, but dangerous headache (2014) J Endocrinol Invest, 37, pp. 789-797
  38. Grand'Maison, S., Weber, F., Bédard, M.J., Pituitary apoplexy in pregnancy: a case series and literature review (2015) Obstet Med, 8, pp. 177-183
  39. Chan, J.L.G.K., Smithson, S.S., Naqvi, M., Mamelak, A.N., Pituitary apoplexy associated with acute COVID-19 infection and pregnancy (2020) Pituitary, 23, pp. 716-720
  40. Sheehan, H., The frequency of post-partum hypopituitarism (1965) J Obstet Gynaecol Br Commonw, 72, pp. 103-111
  41. Frankenne, F., Closset, J., Gomez, F., The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant (1988) J Clin Endocrinol Metab, 66, pp. 1171-1180
  42. Goswami, R., Kochupillai, N., Crock, P.A., Pituitary autoimmunity in patients with Sheehan's syndrome (2002) J Clin Endocrinol Metab, 87, pp. 4137-4141
  43. De Bellis, A., Kelestimur, F., Sinisi, A.A., Anti-hypothalamus and anti-pituitary antibodies may contribute to perpetuate the hypopituitarism in patients with Sheehan's syndrome (2008) Eur J Endocrinol, 158, pp. 147-152
  44. Bichard, L.K., Torpy, D.J., Diabetes insipidus complicating apoplexy during pregnancy: the potential use of copeptin (2020) Intern Med J, 50, pp. 877-879
  45. Furnica, R.M., Gadisseux, P., Fernandez, C., Early diagnosis of Sheehan's syndrome (2015) Anaesth Crit Care Pain Med, 34, pp. 61-63
  46. Feinberg, E.C., Molitch, M.E., Endres, L.K., The incidence of Sheehan's syndrome after obstetric hemorrhage (2005) Fertil Steril, 84, pp. 975-979
  47. Dökmetaş, H.S., Kilicli, F., Korkmaz, S., Characteristic features of 20 patients with Sheehan's syndrome (2006) Gynecol Endocrinol, 22, pp. 279-283
  48. Motivala, S., Gologorsky, Y., Kostandinov, J., Pituitary disorders during pregnancy (2011) Endocrinol Metab Clin N Am, 40, pp. 827-836
  49. Kelestimur, F., Jonsson, P., Molvalilar, S., Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database (2005) Eur J Endocrinol, 152, pp. 581-587
  50. Keleştimur, F., GH deficiency and the degree of hypopituitarism (1995) Clin Endocrinol, 42, pp. 443-444
  51. Kan, A.K., Calligerous, D., A case report of Sheehan syndrome presenting with diabetes insipidus (1998) Aust N Z J Obstet Gynaecol, 38, pp. 224-226
  52. Sheehan, H.L., Whitehead, R., The neurohypophysis in post-partum hypopituitarism (1963) J Pathol Bacteriol, 85, pp. 145-169
  53. Eriksson, L., Frankenne, F., Edèn, S., Hennen, G., Von Schoultz, B., Growth hormone 24 h serum profiles during pregnancy—lack of pulsatility for the secretion of the placental variant (1989) Br J Obstet Gynaecol, 96, p. 949
  54. Fatma, M., Mouna, E., Nabila, R., Sheehan's syndrome with pancytopenia: a case report and review of the literature (2011) J Med Case Rep, 5, p. 490
  55. Lindsay, J.R., Nieman, L.K., The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment (2005) Endocr Rev, 26, pp. 775-799
  56. Keleştimur, F., Sheehan's syndrome (2003) Pituitary, 6, pp. 181-188
  57. See, T.T., Lee, S.P., Chen, H.F., Spontaneous pregnancy and partial recovery of pituitary function in a patient with Sheehan's syndrome (2005) J Chin Med Assoc, 68, pp. 187-190
  58. Laway, B.A., Mir, S., Zargar, A.H., Recovery of prolactin function following spontaneous pregnancy in a woman with Sheehan's syndrome (2013) Indian J Endocrinol Metab, 17, pp. S696-S699
  59. Caturegli, P., Newschaffer, C., Olivi, A., (2005) Autoimmune hypophysitis. Endocr Rev., 26, pp. 599-614
  60. Buxton, N., Robertson, I., Lymphocytic and granulocytic hypophysitis: a single centre experience (2001) Br J Neurosurg, 15, pp. 242-245. , discussion 245-246
  61. Goudie, R.B., Pinkerton, P.H., Anterior hypophysitis and Hashimoto's disease in a young woman (1962) J Pathol Bacteriol, 83, pp. 584-585
  62. Chanson, P., Other pituitary conditions and pregnancy (2019) Endocrinol Metab Clin N Am, 48, pp. 583-603
  63. Bellastella, A., Bizzarro, A., Coronella, C., Lymphocytic hypophysitis: a rare or underestimated disease? (2003) Eur J Endocrinol, 149, pp. 363-376
  64. Glezer, A., Bronstein, M.D., Pituitary autoimmune disease: nuances in clinical presentation (2012) Endocrine, 42, pp. 74-79
  65. Harada, A., Hershman, J.M., Reed, A.W., Comparison of thyroid stimulators and thyroid hormone concentrations in the sera of pregnant women (1979) J Clin Endocrinol Metab, 48, pp. 793-797
  66. Bronstein, M.D., Paraiba, D.B., Jallad, R.S., Management of pituitary tumors in pregnancy (2011) Nat Rev Endocrinol, 7, pp. 301-310
  67. Smith, C.J., Bensing, S., Burns, C., Identification of TPIT and other novel autoantigens in lymphocytic hypophysitis: immunoscreening of a pituitary cDNA library and development of immunoprecipitation assays (2012) Eur J Endocrinol, 166, pp. 391-398
  68. De Bellis, A., Pane, E., Bellastella, G., Detection of antipituitary and antihypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathic hypopituitarism (2011) Clin Endocrinol, 75, pp. 361-366
  69. Lupi, I., Manetti, L., Raffaelli, V., Diagnosis and treatment of autoimmune hypophysitis: a short review (2011) J Endocrinol Invest, 34, pp. e245-252
  70. Thodou, E., Asa, S.L., Kontogeorgos, G., Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings (1995) J Clin Endocrinol Metab, 80, pp. 2302-2311
  71. Molitch, M.E., Gillam, M.P., Lymphocytic hypophysitis (2007) Horm Res, 68, pp. 145-150
  72. Gal, R., Schwartz, A., Gukovsky-Oren, S., Lymphoid hypophysitis associated with sudden maternal death: report of a case review of the literature (1986) Obstet Gynecol Surv, 41, pp. 619-621
  73. Karaca, Z., Tanriverdi, F., Unluhizarci, K., Empty sella may be the final outcome in lymphocytic hypophysitis (2009) Endocr Res, 34, pp. 10-17
  74. Chrisoulidou, A., Boudina, M., Karavitaki, N., Pituitary disorders in pregnancy (2015) Hormones (Basel), 14, pp. 70-80
  75. Honegger, J., Schlaffer, S., Menzel, C., Diagnosis of primary hypophysitis in Germany (2015) J Clin Endocrinol Metab, 100, pp. 3841-3849
  76. Du, X., Yuan, Q., Yao, Y., Hypopituitarism and successful pregnancy (2014) Int J Clin Exp Med, 7, pp. 4660-4665
  77. Davison, J.M., Vallotton, M.B., Lindheimer, M.D., Plasma osmolality and urinary concentration and dilution during and after pregnancy: evidence that lateral recumbency inhibits maximal urinary concentrating ability (1981) Br J Obstet Gynaecol, 88, pp. 472-479
  78. Burrow, G.N., Fisher, D.A., Larsen, P.R., Maternal and fetal thyroid function (1994) N Engl J Med, 331, pp. 1072-1078
  79. Hall, R., Manski-Nankervis, J., Goni, N., Fertility outcomes in women with hypopituitarism (2006) Clin Endocrinol, 65, pp. 71-74
  80. Homburg, R., Eshel, A., Armar, N.A., One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation (1989) BMJ, 298, pp. 809-812
  81. Park, J.K., Murphy, A., Bordeaux, B.L., Dominguez, C.E., Session, D.R., Ovulation induction in a poor responder with panhypopituitarism: a case report and review of the literature (2007) Gynecol Endocrinol, 23, pp. 82-86
  82. Daniel, A., Ezzat, S., Greenblatt, E., Adjuvant growth hormone for ovulation induction with gonadotropins in the treatment of a woman with hypopituitarism (2012) Case Rep Endocrinol, 2012, p. 356429
  83. Thomas, V.P., Sathya, B., George, S., Thomas, N., Pregnancy in a patient with hypopituitarism following surgery and radiation for a pituitary adenoma (2005) J Postgrad Med, 51, pp. 223-224
  84. Giampietro, A., Milardi, D., Bianchi, A., The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature (2009) Fertil Steril, 91 (3). , 930.e7-11
  85. de Boer, J.A., Schoemaker, J., van der Veen, E.A., Impaired reproductive function in women treated for growth hormone deficiency during childhood (1997) Clin Endocrinol, 46, pp. 681-689
  86. Xu, Y.M., Hao, G.M., Gao, B.L., Application of growth hormone in (2019) Front Endocrinol, 10, p. 502
  87. Verhaeghe, J., Bougoussa, M., Van Herck, E., Placental growth hormone and IGF-I in a pregnant woman with Pit-1 deficiency (2000) Clin Endocrinol, 53, pp. 645-647
  88. Shehata, H.A., Okosun, H., Neurological disorders in pregnancy (2004) Curr Opin Obstet Gynecol, 16, pp. 117-122
  89. Vila, G., Akerblad, A.C., Mattsson, A.F., Pregnancy outcomes in women with growth hormone deficiency (2015) Fertil Steril, 104. , 1210.e1211-1217.e1211
  90. Glinoer, D., The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology (1997) Endocr Rev, 18, pp. 404-433
  91. Vila, G., Fleseriu, M., Fertility and pregnancy in women with hypopituitarism: a systematic literature review (2020) J Clin Endocrinol Metab, p. 105
  92. Arlt, W., Allolio, B., Adrenal insufficiency (2003) Lancet, 361, pp. 1881-1893
  93. McKenzie, S.A., Selley, J.A., Agnew, J.E., Secretion of prednisolone into breast milk (1975) Arch Dis Child, 50, pp. 894-896
  94. LaFranchi, S., Thyroid hormone in hypopituitarism, Graves' disease, congenital hypothyroidism, and maternal thyroid disease during pregnancy (2006) Growth Hormone IGF Res, 16, pp. S20-S24
  95. Wang, Y.F., Yang, H.X., Clinical analysis of hypothyroidism during pregnancy (2007) Zhonghua Fu Chan Ke Za Zhi, 42, pp. 157-160
  96. Ananthakrishnan, S., Diabetes insipidus in pregnancy: etiology, evaluation, and management (2009) Endocr Pract, 15, pp. 377-382
  97. Kalelioglu, I., Uzum, A.K., Yildirim, A., Transient gestational diabetes insipidus diagnosed in successive pregnancies: review of pathophysiology, diagnosis, treatment, and management of delivery (2007) Pituitary, 10, pp. 87-93
  98. Ray, J.G., DDAVP use during pregnancy: an analysis of its safety for mother and child (1998) Obstet Gynecol Surv, 53, pp. 450-455
  99. Zeeman, G.G., Khan-Dawood, F.S., Dawood, M.Y., Oxytocin and its receptor in pregnancy and parturition: current concepts and clinical implications (1997) Obstet Gynecol, 89, pp. 873-883
  100. Wm, H., Pre-existing endocrine disease in relation to pregnancy (1999) Curr Obstet Gynaecol, 9, pp. 62-68
  101. Dürr, J.A., Diabetes insipidus in pregnancy (1987) Am J Kidney Dis, 9, pp. 276-283
  102. Mandel, S.J., Larsen, P.R., Seely, E.W., Increased need for thyroxine during pregnancy in women with primary hypothyroidism (1990) N Engl J Med, 323, pp. 91-96
  103. Källén, B.A., Carlsson, S.S., Bengtsson, B.K., Diabetes insipidus and use of desmopressin (Minirin) during pregnancy (1995) Eur J Endocrinol, 132, pp. 144-146
  104. Pivonello, R., De Martino, M.C., Auriemma, R.S., Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status (2014) J Endocrinol Invest, 37, pp. 99-112
  105. Sonigo, C., Bouilly, J., Carré, N., Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration (2012) J Clin Invest, 122, pp. 3791-3795
  106. Palejwala, S.K., Conger, A., Eisenberg, A.A., Cohan, P., Griffiths, C.F., Barkhoudarian, G., Kelly, D.F., Pregnancy-associated Cushing's disease? An exploratory retrospective study (2018) Pituitary, 21, pp. 584-592
  107. Miyai, K.I.K., Kondo, K., Mori, S., Asymptomatic hyperprolactinaemia and prolactinoma in the general population--mass screening by paired assays of serum prolactin (1986) Clin Endocrinol, 25, pp. 549-554
  108. Holdaway, I.M., Rajasoorya, C., Epidemiology of acromegaly (1999) Pituitary, 2, pp. 29-41
  109. Daly, A.F., Rixhon, M., Adam, C., High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium (2006) J Clin Endocrinol Metab, 91, pp. 4769-4775
  110. Cozzi, R., Attanasio, R., Barausse, M., Pregnancy in acromegaly: a one-center experience (2006) Eur J Endocrinol, 155, pp. 279-284
  111. Cheng, S., Grasso, L., Martinez-Orozco, J.A., Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature (2012) Clin Endocrinol, 76, pp. 264-271
  112. Grynberg, M., Salenave, S., Young, J., Female gonadal function before and after treatment of acromegaly (2010) J Clin Endocrinol Metab, 95, pp. 4518-4525
  113. Pivonello, R., De Leo, M., Cozzolino, A., The treatment of Cushing's disease (2015) Endocr Rev, 36, pp. 385-486
  114. Colao, A.L.G., Growth-hormone and prolactin excess (1998) Lancet, 31, pp. 1455-1461
  115. Vance, M.L.T.M., PRL: HyperPRLemic syndromes and management (1989) Textbook of endocrinology, pp. 408-418. , L. De Groot (Eds), 2nd ed., Philadelphia: WB Saunders Company
  116. Webster, J., Piscitelli, G., Polli, A., A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group (1994) N Engl J Med, 331, pp. 904-909
  117. Tang, K., Lu, L., Feng, M., The incidence of pregnancy-associated Cushing's disease and its relation to pregnancy: a retrospective study (2020) Front Endocrinol, 11, p. 305
  118. Melmed, S., Casanueva, F.F., Hoffman, A.R., Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline (2011) J Clin Endocrinol Metab, 96, pp. 273-288
  119. Lamba, N., Noormohamed, N., Simjian, T., Fertility after transsphenoidal surgery in patients with prolactinomas: a meta-analysis (2019) Clin Neurol Neurosurg, 176, pp. 53-60
  120. Yi, N.J.L., Zhang, Q., Zhang, S., Liu, X., Shou, X., Lu, B., Long-term follow-up of female prolactinoma patients at child-bearing age after transsphenoidal surgery (2018) Endocrine, 62, pp. 76-82
  121. Molitch, M.E., Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma (2015) Eur J Endocrinol, 172, pp. R205-R213
  122. Women with prolactinoma-effect of pregnancy and lactation on serum prolactin and on tumour growth (1986) Acta Endocrinol
  123. Sant' Anna, B.G., Musolino, N.R.C., Gadelha, M.R., A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas (2020) Pituitary, 23, pp. 120-128
  124. Barraud, S., Guédra, L., Delemer, B., Evolution of macroprolactinomas during pregnancy: a cohort study of 85 pregnancies (2020) Clin Endocrinol, 92, pp. 421-427
  125. Astaf'eva, L.I., Sidneva, Y.G., Kadashev, B.A., Restoration of fertility in a woman with giant prolactinoma in response to cabergoline treatment (2019) Endocrinol Diabetes Metab Case Rep, 2019
  126. Persiani, S., Sassolas, G., Piscitelli, G., Pharmacodynamics and relative bioavailability of cabergoline tablets vs solution in healthy volunteers (1994) J Pharm Sci, 83, pp. 1421-1424
  127. Hurault-Delarue, C., Montastruc, J.L., Beau, A.B., Pregnancy outcome in women exposed to dopamine agonists during pregnancy: a pharmacoepidemiology study in EFEMERIS database (2014) Arch Gynecol Obstet, 290, pp. 263-270
  128. Chico, A.M.J., Halperin, I., Osaba, M.J.M., Adelantado, J., Webb, S.M., Cushing's disease and pregnancy: report of six cases (1996) Eur J Obst Gynecol, pp. 143-146
  129. Glezer, A., Bronstein, M.D., Prolactinomas, cabergoline, and pregnancy (2014) Endocrine, 47, pp. 64-69
  130. Rastogi, A., Bhadada, S.K., Bhansali, A., Pregnancy and tumor outcomes in infertile women with macroprolactinoma on cabergoline therapy (2017) Gynecol Endocrinol, 33, pp. 270-273
  131. Karaca, Z., Yarman, S., Ozbas, I., How does pregnancy affect the patients with pituitary adenomas: a study on 113 pregnancies from Turkey (2018) J Endocrinol Invest, 41, pp. 129-141
  132. Lambert, K., Rees, K., Seed, P.T., Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes (2017) Obstet Gynecol, 129, pp. 185-194
  133. Bronstein, M.D., Prolactinomas and pregnancy (2005) Pituitary, 8, pp. 31-38
  134. Raymond, J.P., Goldstein, E., Konopka, P., Follow-up of children born of bromocriptine-treated mothers (1985) Horm Res, 22, pp. 239-246
  135. Krupp, P.M.C., Richter, K., The safety aspects of infertility treatments (1988) Presented at: Program of the second World Congress of Gynecology and Obstetrics, 9
  136. Ono, M., Miki, N., Amano, K., Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas (2010) J Clin Endocrinol Metab, 95, pp. 2672-2679
  137. Lebbe, M., Hubinont, C., Bernard, P., Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women (2010) Clin Endocrinol, 73, pp. 236-242
  138. Stalldecker, G., Mallea-Gil, M.S., Guitelman, M., Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature (2010) Pituitary, 13, pp. 345-350
  139. Mellor, A., Harvey, R.D., Pobereskin, L.H., Cushing's disease treated by trans-sphenoidal selective adenomectomy in mid-pregnancy (1998) Br J Anaesth, 80, pp. 850-852
  140. Peillon, F.R.J., Moussy, D., Vila-Porcile, E., Olivier, L., Racadot, O., PRL-secreting adenomas. A correlative study of morphological and clinical data (1978) Treatment of pituitary adenomas, p. 114. , R. Fahlbusch, V.K. Von Werder (Eds), Stuttgart: Thiemi
  141. Sant’ Anna, B.G., Musolino, N.R.C., Gadelha, M.R., A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas (2020) Pituitary, 23 (2), pp. 120-128
  142. Musolino, N., Bronstein, M., PRLomas and pregnancy (2001) Pituitary tumors in pregnancy, pp. 91-108. , M. Bronstein (Eds), Boston: Kluwer Academic Publishers
  143. Auriemma, R.S., Perone, Y., Di Sarno, A., Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation (2013) J Clin Endocrinol Metab, 98, pp. 372-379
  144. Domingue, M.E., Devuyst, F., Alexopoulou, O., Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients (2014) Clin Endocrinol, 80, pp. 642-648
  145. O'Sullivan, S.M., Farrant, M.T., Ogilvie, C.M., An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists (2020) Aust N Z J Obstet Gynaecol, 60, pp. 405-411
  146. Crosignani, P.G., Mattei, A.M., Severini, V., Long-term effects of time, medical treatment and pregnancy in 176 hyperprolactinemic women (1992) Eur J Obstet Gynecol Reprod Biol, 44, pp. 175-180
  147. Huda, M.S., Athauda, N.B., Teh, M.M., Factors determining the remission of microprolactinomas after dopamine agonist withdrawal (2010) Clin Endocrinol, 72, pp. 507-511
  148. Dias, M.L., Vieira, J.G., Abucham, J., Detecting and solving the interference of pregnancy serum, in a GH immunometric assay (2013) Growth Hormone IGF Res, 23, pp. 13-18
  149. Eriksson, L., Edén, S., Fröhlander, N., Continuous 24-hour secretion of growth hormone during late pregnancy. A regulator of maternal metabolic adjustment? (1988) Acta Obstet Gynecol Scand, 67, pp. 543-547
  150. Cabezón, C., Bruno, O.D., Cohen, M., García, S., Gutman, R.A., Twin pregnancy in a patient with Cushing's disease (1999) Fertil Steril, 72, pp. 371-372
  151. Beckers, A., Stevenaert, A., Foidart, J.M., Placental and pituitary growth hormone secretion during pregnancy in acromegalic women (1990) J Clin Endocrinol Metab, 71, pp. 725-731
  152. Kaltsas, G.A., Mukherjee, J.J., Jenkins, P.J., Menstrual irregularity in women with acromegaly (1999) J Clin Endocrinol Metab, 84, pp. 2731-2735
  153. Kaltsas, G.A., Androulakis, I.I., Tziveriotis, K., Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly (2007) Clin Endocrinol, 67, pp. 917-922
  154. Katznelson, L., Kleinberg, D., Vance, M.L., Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study (2001) Clin Endocrinol, 54, pp. 183-188
  155. Jamnongjit, M., Gill, A., Hammes, S.R., Epidermal growth factor receptor signaling is required for normal ovarian steroidogenesis and oocyte maturation (2005) Proc Natl Acad Sci U S A, 102, pp. 16257-16262
  156. Caron, P., Broussaud, S., Bertherat, J., Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women (2010) J Clin Endocrinol Metab, 95, pp. 4680-4687
  157. Hannon, A.M., Frizelle, I., Kaar, G., Octreotide use for rescue of vision in a pregnant patient with acromegaly (2019) Endocrinol Diabetes Metab Case Rep, 2019
  158. Atmaca, A., Dagdelen, S., Erbas, T., Follow-up of pregnancy in acromegalic women: different presentations and outcomes (2006) Exp Clin Endocrinol Diabetes, 114, pp. 135-139
  159. Boulanger, C., Vezzosi, D., Bennet, A., Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide (2004) J Endocrinol Invest, 27, pp. 465-470
  160. Caron, P., Gerbeau, C., Pradayrol, L., Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide) (1996) J Clin Endocrinol Metab, 81, pp. 1164-1168
  161. Sheeler, L.R., Cushing's syndrome and pregnancy (1994) Endocrinol Metab Clin N Am, 23, pp. 619-627
  162. Molitch, M.E., Pituitary tumors and pregnancy (2003) Growth Hormone IGF Res, 13, pp. S38-S44
  163. Herman-Bonert, V., Seliverstov, M., Melmed, S., Pregnancy in acromegaly: successful therapeutic outcome (1998) J Clin Endocrinol Metab, 83, pp. 727-731
  164. Vialon, M., Grunenwald, S., Mouly, C., Gestational diabetes and acromegaly: single-centre experience of 14 pregnancies (2019) Clin Endocrinol, 91, pp. 805-809
  165. Caron, P., Gerbeau, C., Pradayrol, L., Maternal-fetal transfer of octreotide (1995) N Engl J Med, 333, pp. 601-602
  166. Katznelson, L., Laws, E.R., Melmed, S., Acromegaly: an endocrine society clinical practice guideline (2014) J Clin Endocrinol Metab, 99, pp. 3933-3951
  167. Caron, P., Buscail, L., Beckers, A., Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy (1997) J Clin Endocrinol Metab, 82, pp. 3771-3776
  168. Maffei, P., Tamagno, G., Nardelli, G.B., Effects of octreotide exposure during pregnancy in acromegaly (2010) Clin Endocrinol, 72, pp. 668-677
  169. Araujo, P.B., Vieira Neto, L., Gadelha, M.R., Pituitary tumor management in pregnancy (2015) Endocrinol Metab Clin N Am, 44, pp. 181-197
  170. van der Lely, A.J., Gomez, R., Heissler, J.F., Pregnancy in acromegaly patients treated with pegvisomant (2015) Endocrine, 49, pp. 769-773
  171. Brian, S.R., Bidlingmaier, M., Wajnrajch, M.P., Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects (2007) J Clin Endocrinol Metab, 92, pp. 3374-3377
  172. Wallace, C., Toth, E.L., Lewanczuk, R.Z., Siminoski, K., Pregnancy-induced Cushing's syndrome in multiple pregnancies (1996) J Clin Endocrinol Metab, 81, pp. 15-21
  173. Carr, B.R., Parker, C.R., Madden, J.D., Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy (1981) Am J Obstet Gynecol, 139, pp. 416-422
  174. Jung, C., Ho, J.T., Torpy, D.J., A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum (2011) J Clin Endocrinol Metab, 96, pp. 1533-1540
  175. Lopes, L.M., Francisco, R.P., Galletta, M.A., Determination of nighttime salivary cortisol during pregnancy: comparison with values in non-pregnancy and Cushing's disease (2016) Pituitary, 19, pp. 30-38
  176. Escourolle, H.A.J., Bertagna, X., Guilhaume, B., Pariente, D., Derome, P., Bonnin, A., Luton, J.P., Comparison of computerized tomography and magnetic resonance imaging for the examination of the pituitary gland in patients with Cushing's disease (1993) Clin Endocrinol, 39, pp. 307-313
  177. Buchfelder, M., Nistor, R., Fahlbusch, R., The accuracy of CT and MR evaluation of the sella turcica for detection of adrenocorticotropic hormone-secreting adenomas in Cushing disease (1993) AJNR Am J Neuroradiol, 14, pp. 1183-1190
  178. Kasperlik-Załuska, A.A., Nielubowicz, J., Wisławski, J., Nelson's syndrome: incidence and prognosis (1983) Clin Endocrinol, 19, pp. 693-698
  179. Surrey, E.S., Chang, R.J., Nelson's syndrome in pregnancy (1985) Fertil Steril, 44, pp. 548-551
  180. Igoe, D., Pidgeon, C., Dinn, J., Nelson's syndrome following partial pituitary microadenomectomy and pregnancy (1992) Clin Endocrinol, 36, pp. 429-432
  181. Leiba, S., Kaufman, H., Winkelsberg, G., Pregnancy in a case of Nelson's syndrome (1978) Acta Obstet Gynecol Scand, 57, pp. 373-375
  182. Feeney, J.G., Craig, G.A., Hancock, K.W., Pregnancy and Nelson's syndrome. Two case reports (1978) Br J Obstet Gynaecol, 85, pp. 715-718
  183. Boronat, M., Marrero, D., Lopez-Plasencia, Y., Successful outcome of pregnancy in a patient with Cushing's disease under treatment with ketoconazole during the first trimester of gestation (2011) Gynecol Endocrinol, 27, pp. 675-677
  184. Jornayvaz, F.R., Assie, G., Bienvenu-Perrard, M., Pregnancy does not accelerate corticotroph tumor progression in Nelson's syndrome (2011) J Clin Endocrinol Metab, 96, pp. E658-E662